GET DAILY SIGNALSWhy Is Oscar Health (OSCR) Stock Down -7.56% Today?
Key Takeaways
- OSCR shares fell 7.56% in today's session, extending a post-earnings reversal.
- The decline follows strong Q3 results that beat estimates but raised questions about the "quality" of the beat.
- Roughly $250 million of the revenue upside stemmed from a risk-adjustment accounting change rather than organic growth.
- Profit-taking hit the stock after a post-midterm rally pushed it to a 52-week high near $38.50 earlier this week.
- Insider selling by the company's CFO and lingering Affordable Care Act (ACA) policy uncertainty added pressure.
- Traders are watching membership trends, 2027 ACA pricing, and whether key technical levels hold.
- For more detail on Price Targets, Earnings, and Forecast, explore Tickeron's dedicated pages for OSCR.
- Discover how AI-driven strategies are navigating volatile names like this on Tickeron's Trending AI Robots page.
Opening Summary
OSCR — Oscar Health, Inc., a technology-driven health insurance company focused on Affordable Care Act marketplace plans, individual and family coverage, and small-group offerings — is trading sharply lower on Thursday. The stock fell 7.56% to $30.67, down from a prior close of $33.18. The decline extends a sell-off that began after the company's third-quarter earnings report, as investors weighed the composition of a headline-beating quarter against profit-taking following a powerful multi-day rally.
Post-Earnings Reversal: Scrutinizing the "Quality" of the Beat
The primary driver of today's move is a deepening post-earnings reversal. Oscar Health reported Q3 adjusted earnings of $0.49 per share, reversing a year-ago loss and crushing consensus estimates for a loss of roughly $0.14. Revenue surged 72% to about $5.14 billion, well above forecasts, and management raised its full-year 2026 operating earnings outlook for the third time, to a range of $850 million to $950 million.
Despite the strong headline numbers, the market has been questioning the durability of the beat. Approximately $250 million of the revenue upside came from a change in the company's accounting for risk-adjustment payments to other ACA insurers, rather than from fundamental membership or premium growth. Because risk-adjustment is designed to redistribute funds between insurers based on the health of their member pools, investors treated this portion of the results as lower-quality and potentially non-recurring, fueling the earnings-driven move lower.
Profit-Taking After a Post-Midterm Rally
The stock's decline also reflects aggressive profit-taking. Oscar Health shares spiked more than 8% on Wednesday and touched a 52-week high near $38.50 after the midterm elections, as investors bet that a shift in Washington could revive enhanced ACA subsidies and support enrollment. With the stock up roughly 150% year to date, the gap between the recent peak and today's levels suggests traders are locking in gains while re-evaluating how quickly — and whether — any policy tailwind materializes.
ACA Uncertainty and Insider Selling
Broader policy concerns continue to weigh on sentiment. Questions around the future of enhanced ACA subsidies and reports of potential enrollment reductions have clouded the outlook for insurers most exposed to the individual marketplace. Against this backdrop, a disclosure that CFO Richard Blackley sold roughly $2.75 million in company stock added a further note of caution, as insider sales can be read by the market as a signal about management's confidence in the near-term outlook.
Market Context and Trading Activity
Trading volume was elevated relative to the stock's average, consistent with heavy repositioning following earnings and the prior day's election-driven surge. The move diverged from the broader healthcare sector, which was relatively flat, underscoring that the selling pressure was company-specific rather than a broad risk-off rotation. From a technical standpoint, OSCR slipped below its 20-day moving average and is testing support near its 50-day moving average, while remaining above its longer-term 200-day average — a setup traders are watching closely for signs of whether the pullback stabilizes or deepens.
What Comes Next for OSCR
Looking ahead, investors will focus on membership trends and the company's medical loss ratio as indicators of whether profitability gains can be sustained. Key areas of attention include 2027 ACA pricing decisions, any legislative progress on subsidy extensions, and the next quarterly enrollment figures. The raised guidance implies a potential fourth-quarter operating loss and a lower year-end membership outlook, factors that could keep volatility elevated. Risks include regulatory shifts, competitive pricing pressure in the ACA market, and the possibility that the stock's sharp 2026 run leaves little room for error relative to expectations.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of the platform's strongest-performing AI trading bots under current market conditions. Tickeron offers hundreds of automated strategies covering thousands of tickers, and these bots vary by trading approach, timeframe, performance metrics, and the symbols they trade. Only the top performers are featured in this section, giving traders a focused view of what is working right now. Explore the Trending AI Robots to see how AI-driven strategies are responding to today's market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
OSCR in upward trend: price rose above 50-day moving average on November 03, 2026
OSCR moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 58 cases where OSCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for OSCR just turned positive on November 04, 2026. Looking at past instances where OSCR's MACD turned positive, the stock continued to rise in 35 of 41 cases over the following month. The odds of a continued upward trend are 85%.
Following a +13.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSCR advanced for three days, in 232 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Aroon Indicator entered an Uptrend today. In 178 of 225 cases where OSCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSCR as a result. In 63 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The 10-day moving average for OSCR crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
OSCR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating fairly steady price growth. OSCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.991) is normal, around the industry mean (3.530). P/E Ratio (20.868) is within average values for comparable stocks, (131.451). OSCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.618) is also within normal values, averaging (0.569).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ManagedHealthCare